Loading…
Loading…
Don't overthink it. These are blue chip stocks that have simply gone on sale and would be solid additions to almost any income portfolio.
Target's Roundel advertising business gains momentum, with rising revenues, higher-margin opportunities and technology investments strengthening its growth outlook.
Despite the tech giant printing record revenues, the stock has managed a gain of barely 10% so far in 2026 and sits roughly where it stood 12 months ago. It's safe to say investors have been feeling a bit hard done by and are due for some good news.
AUSTIN, Texas--(BUSINESS WIRE)--Vital Farms (Nasdaq: VITL) announced today the pilot launch of Vital Farms Free-Range eggs, which are expected to arrive in select Target retail stores across the South and Southeast beginning this week. This limited test is designed to explore how Vital Farms can reach more households with a high-quality product at a more accessible suggested retail price point of less than $5 per carton, while maintaining its commitment to transparency and animal welfare. Intro.
Bank of America Securities on Friday upgraded Pharvaris N.V. (NASDAQ:PHVS), citing an attractive entry point with clinical risk largely removed.
Products and components from Elmet Group are found in an array of defense-related equipment. Shares are up 49% from its April IPO.
Target (TGT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
OpenAI slashed its funding ask by a staggering amount just as public AI stocks cratered, and the timing raises serious questions about what private investors know that the market does not.